rs199795381
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_024339.5(THOC6):c.569G>A(p.Gly190Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000213 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00022 ( 0 hom. )
Consequence
THOC6
NM_024339.5 missense
NM_024339.5 missense
Scores
7
9
2
Clinical Significance
Conservation
PhyloP100: 5.69
Genes affected
THOC6 (HGNC:28369): (THO complex subunit 6) This gene encodes a subunit of the multi-protein THO complex, which is involved in coordination between transcription and mRNA processing. The THO complex is a component of the TREX (transcription/export) complex, which is involved in transcription and export of mRNAs. A missense mutation in this gene is associated with a neurodevelopmental disorder called Beaulieu-Boycott-Innes syndrome. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.969
PP5
Variant 16-3026764-G-A is Pathogenic according to our data. Variant chr16-3026764-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 561208.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, not_provided=1, Uncertain_significance=1, Pathogenic=2}. Variant chr16-3026764-G-A is described in Lovd as [Likely_pathogenic]. Variant chr16-3026764-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THOC6 | NM_024339.5 | c.569G>A | p.Gly190Glu | missense_variant | 8/13 | ENST00000326266.13 | NP_077315.2 | |
THOC6 | NM_001347704.2 | c.569G>A | p.Gly190Glu | missense_variant | 9/14 | NP_001334633.1 | ||
THOC6 | NM_001347703.2 | c.497G>A | p.Gly166Glu | missense_variant | 9/14 | NP_001334632.1 | ||
THOC6 | NM_001142350.3 | c.569G>A | p.Gly190Glu | missense_variant | 8/12 | NP_001135822.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THOC6 | ENST00000326266.13 | c.569G>A | p.Gly190Glu | missense_variant | 8/13 | 1 | NM_024339.5 | ENSP00000326531 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152188Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
20
AN:
152188
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000100 AC: 25AN: 250076Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135264
GnomAD3 exomes
AF:
AC:
25
AN:
250076
Hom.:
AF XY:
AC XY:
15
AN XY:
135264
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000221 AC: 323AN: 1461648Hom.: 0 Cov.: 38 AF XY: 0.000215 AC XY: 156AN XY: 727096
GnomAD4 exome
AF:
AC:
323
AN:
1461648
Hom.:
Cov.:
38
AF XY:
AC XY:
156
AN XY:
727096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152188Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74344
GnomAD4 genome
AF:
AC:
20
AN:
152188
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
74344
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
13
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:8Uncertain:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome Pathogenic:3Uncertain:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 17, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Jan 01, 2014 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 07, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Aug 28, 2019 | A homozygous missense variant was identified, NM_024339.4(THOC6):c.569G>A in exon 8 of 13 of the THOC6 gene. This substitution is predicted to cause a moderate amino acid change from glycine to glutamic acid at position 190 of the protein, NP_077315.2(THOC6):p.(Gly190Glu). The glycine at this position has high conservation (100 vertebrates, UCSC), and is located in the WD4 functional domain. In silico software predicts the missense variant to be disease causing (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a frequency of 0.0002% (28 heterozygotes, 0 homozygotes). It has been previously reported in patients with Beaulieu-Boycott-Innes syndrome (ClinVar, Amos, J. et al (2017), Mattioli, F. et al (2019)). In addition, functional studies show that this variant causes abnormal nuclear localisation and decreased THOC1/THOC5 interaction (Mattioli, F. et al (2019)). Based on information available at the time of curation, this variant has been classified as LIKELY PATHOGENIC. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
not provided Pathogenic:4
Likely pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 29, 2023 | Published functional studies demonstrate a damaging effect where G190E is detrimental to protein function (Mattioli et al., 2018); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27102954, 30476144, 31421288, 31216405, 34740920, 27535533) - |
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
THOC6-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 17, 2023 | The THOC6 c.569G>A variant is predicted to result in the amino acid substitution p.Gly190Glu. This variant was reported in the compound heterozygous state in at least three unrelated individuals with intellectual disability and/or neurodevelopmental phenotypes (Amos et al. 2017. PubMed ID: 27102954; Mattioli et al. 2019. PubMed ID: 30476144; Liu et al. 2019. PubMed ID: 31216405). Functional studies showed that this variant results in abnormal subcellular localization and impaired protein-protein interaction (Mattioli et al. 2019. PubMed ID: 30476144). This variant is reported in 0.020% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-3076765-G-A). This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;.;.;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;.;D
REVEL
Pathogenic
Sift4G
Pathogenic
D;D;D;D
Polyphen
D;.;.;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at